Cargando…

Preparation of Losartan Potassium Controlled Release Matrices and In-Vitro Investigation Using Rate Controlling Agents

Controlled release matrices have predictable drug release kinetics, provide drugs for an extended period of time, and reduce dosing frequency with improved patient compliance as compared with conventional tablet dosage forms. In the current research work, losartan potassium controlled release matrix...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khan, Kamran Ahmad, Khan, Gul Majid, Muzammal, Muhammad, Al Mohaini, Mohammed, Alsalman, Abdulkhaliq J., Al Hawaj, Maitham A., Ahmad, Ashfaq, Niazi, Zahid Rasul, Shah, Kifayat Ullah, Farid, Arshad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8839457/ https://www.ncbi.nlm.nih.gov/pubmed/35164127 http://dx.doi.org/10.3390/molecules27030864

Ejemplares similares

Tacrolimus-Loaded Solid Lipid Nanoparticle Gel: Formulation Development and In Vitro Assessment for Topical Applications
por: Khan, Abdul Shakur, et al.
Publicado: (2022)

Preparation and In Vitro Evaluation of Controlled-Release Matrices of Losartan Potassium Using Ethocel Grade 10 and Carbopol 934P NF as Rate-Controlling Polymers
por: Khan, Kamran Ahmad, et al.
Publicado: (2022)

In Silico Analysis of the L-2-Hydroxyglutarate Dehydrogenase Gene Mutations and Their Biological Impact on Disease Etiology
por: Muzammal, Muhammad, et al.
Publicado: (2022)

In Silico Analysis Identified Putative Pathogenic Missense nsSNPs in Human SLITRK1 Gene
por: Ali, Muhammad Zeeshan, et al.
Publicado: (2022)

In Vitro and Ex Vivo Evaluation of Fluocinolone Acetonide–Acitretin-Coloaded Nanostructured Lipid Carriers for Topical Treatment of Psoriasis
por: Raza, Hassan, et al.
Publicado: (2022)

Formulation and Characterization of Chitosan-Decorated Multiple Nanoemulsion for Topical Delivery In Vitro and Ex Vivo
por: Malik, Muhammad Rehan, et al.
Publicado: (2022)

Formulation and Evaluation of Hydrophilic Polymer Based Methotrexate Patches: In Vitro and In Vivo Characterization
por: Latif, Muhammad Shahid, et al.
Publicado: (2022)

Obviation of dyslipidemia by garlic oil and its organosulfur compound, diallyl disulphide, in experimental animals
por: Mohammed Basheeruddin Asdaq, Syed, et al.
Publicado: (2022)

Insights into the Protective Effects of Thymoquinone against Toxicities Induced by Chemotherapeutic Agents
por: Farooq, Juveriya, et al.
Publicado: (2021)

The role of serotonergic and catecholaminergic systems for possible antidepressant activity of apigenin
por: Al-Yamani, Mohammad J., et al.
Publicado: (2022)

Preparation and Characterization of Controlled-Release Floating Bilayer Tablets of Esomeprazole and Clarithromycin
por: Israr, Muhammad, et al.
Publicado: (2022)

Wireless Networking-Driven Healthcare Approaches in Combating COVID-19
por: BasheeruddinAsdaq, Syed Mohammed, et al.
Publicado: (2021)

Elevated Vulnerability of Chronic Leukemia Patients to COVID-19 Infection: A Systems Biology Approach
por: Alsalman, Abdulkhaliq J., et al.
Publicado: (2022)

Mimosa pudica mucilage nanoparticles of losartan potassium: Characterization and pharmacodynamics evaluation
por: Ghumman, Shazia Akram, et al.
Publicado: (2023)

Development and evaluation of chitosan based oral controlled matrix tablets of losartan potassium
por: Rao, Tallapaneni Vishnuvardhan, et al.
Publicado: (2012)

Hydrochlorothiazide/Losartan Potassium Tablet Prepared by Direct Compression
por: Luo, Qiuhua, et al.
Publicado: (2022)

Synthesis and Characterization of Nanoporous Carbon Carriers for Losartan Potassium Delivery
por: Ejsmont, Aleksander, et al.
Publicado: (2021)

Polymeric Microparticles: Synthesis, Characterization and In Vitro Evaluation for Pulmonary Delivery of Rifampicin
por: Naz, Faiqa Falak, et al.
Publicado: (2022)

Physicochemical Characterization of Chitosan-Decorated Finasteride Solid Lipid Nanoparticles for Skin Drug Delivery
por: Sohaib, Muhammad, et al.
Publicado: (2022)

RP-HPLC Method for the Determination of Losartan Potassium and Ramipril in Combined Dosage Form
por: Rao, K. Srinivasa, et al.
Publicado: (2010)

Design and In Vitro Evaluation of Compression-coated Pulsatile Release Tablets of Losartan Potassium
por: Bajpai, M., et al.
Publicado: (2012)

Human Bioequivalence Evaluation of Two Losartan Potassium Tablets Under Fasting Conditions
por: Das, A. K., et al.
Publicado: (2015)

Pharmaceutical Development of Film-Coated Mini-Tablets with Losartan Potassium for Epidermolysis Bullosa
por: Elezaj, Valentinë, et al.
Publicado: (2022)

Role of various natural, synthetic and semi-synthetic polymers on drug release kinetics of losartan potassium oral controlled release tablets
por: Jayasree, J., et al.
Publicado: (2014)

A Rare Case of Dose-Dependent Losartan-Induced Angioedema
por: Niazi, Bilal A, et al.
Publicado: (2022)

Spectrophotometric and HPLC Methods for Simultaneous Estimation of Amlodipine Besilate, Losartan Potassium and Hydrochlorothiazide in Tablets
por: Wankhede, S. B., et al.
Publicado: (2010)

Sensitive and accurate estimation of losartan potassium formulation by high-performance thin-layer chromatography
por: Selvadurai, Muralidharan, et al.
Publicado: (2011)

Formulation and optimization of mucoadhesive buccal patches of losartan potassium by using response surface methodology
por: Ikram, Md., et al.
Publicado: (2015)

Losartan Potassium and Verapamil Hydrochloride Compound Transdermal Drug Delivery System: Formulation and Characterization
por: Chen, Yu-si, et al.
Publicado: (2022)

Randomized placebo‐controlled trial of losartan for pediatric NAFLD
por: Vos, Miriam B., et al.
Publicado: (2022)

Potassium 2-iodobenzenesulfonate monohydrate
por: Arshad, Muhammad Nadeem, et al.
Publicado: (2008)

Efficacy of Losartan in the management of Post-Dialysis Euvolemic Hypertension (HELD-Trial): A Single-Blind Randomized Control Trial
por: Aftab, Raja Ahsan, et al.
Publicado: (2016)

A Method for Content Uniformity Determination of Atenolol and Losartan Potassium in Combined Tablet Dosage Form
por: Shah, S. A., et al.
Publicado: (2010)

Validated RP-HPLC Method for Simultaneous Quantitation of Losartan Potassium and Metolazone in Bulk Drug and Formulation
por: Dubey, Ramkumar, et al.
Publicado: (2011)

Spectrophotometric method for simultaneous estimation of atenolol in combination with losartan potassium and hydrochlorothiazide in bulk and tablet formulation
por: Bari, Sanjay, et al.
Publicado: (2010)

Evaluation of Potential Herb-Drug Interactions Between Shengmai Injection and Losartan Potassium in Rat and In Vitro
por: Niu, Zhenchao, et al.
Publicado: (2022)

Meta-analysis of the effectiveness and safety of Shenyankangfu tablets combined with losartan potassium in the treatment of chronic glomerulonephritis
por: Feng, Pan-Feng, et al.
Publicado: (2022)

Degradation of Losartan Potassium Highlighted by Correlated Studies of Photoluminescence, Infrared Absorption Spectroscopy and Dielectric Spectroscopy
por: Paraschiv, Mirela, et al.
Publicado: (2022)

Efficacy and safety of single-pill amlodipine/losartan versus losartan in patients with inadequately controlled hypertension after losartan treatment: a multicenter, double-blind, randomized phase III clinical trial
por: Zhang, Shuyang, et al.
Publicado: (2023)

Abelmoschus manihot – a traditional Chinese medicine versus losartan potassium for treating IgA nephropathy: study protocol for a randomized controlled trial
por: Li, Ping, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_jgg2i0nq4af6u33hbctrtor13g